These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 31167608)

  • 1. Evaluating Prognostic Factors for Liver Transplantation Among United States Patients With Hereditary Transthyretin-Mediated (hATTR) Amyloidosis Using National Registry Data.
    Brandman D; Lin H; McManus A; Agarwal S; Gache LM; Irish W; Gollob J; Živković SA
    Prog Transplant; 2019 Sep; 29(3):213-219. PubMed ID: 31167608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of Patients With Familial Transthyretin Amyloidosis After Liver Transplantation.
    Banerjee D; Roeker LE; Grogan M; Swiecicki P; Poterucha J; Heimbach J; Zeldenrust S; Gertz M; Edwards B; Daly R; Klarich KW; Dispenzieri A
    Prog Transplant; 2017 Sep; 27(3):246-250. PubMed ID: 29187090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver Transplantation for Hereditary Transthyretin Amyloidosis: After 20 Years Still the Best Therapeutic Alternative?
    Ericzon BG; Wilczek HE; Larsson M; Wijayatunga P; Stangou A; Pena JR; Furtado E; Barroso E; Daniel J; Samuel D; Adam R; Karam V; Poterucha J; Lewis D; Ferraz-Neto BH; Cruz MW; Munar-Ques M; Fabregat J; Ikeda S; Ando Y; Heaton N; Otto G; Suhr O
    Transplantation; 2015 Sep; 99(9):1847-54. PubMed ID: 26308415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does recipient work status pre-transplant affect post-heart transplant survival? A United Network for Organ Sharing database review.
    Ravi Y; Lella SK; Copeland LA; Zolfaghari K; Grady K; Emani S; Sai-Sudhakar CB
    J Heart Lung Transplant; 2018 May; 37(5):604-610. PubMed ID: 29482932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low, rather than high, body mass index confers increased risk for post-liver transplant death and graft loss: Risk modulated by model for end-stage liver disease.
    Bambha KM; Dodge JL; Gralla J; Sprague D; Biggins SW
    Liver Transpl; 2015 Oct; 21(10):1286-94. PubMed ID: 26097202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac Dysautonomia Predicts Long-Term Survival in Hereditary Transthyretin Amyloidosis After Liver Transplantation.
    Algalarrondo V; Antonini T; Théaudin M; Chemla D; Benmalek A; Lacroix C; Castaing D; Cauquil C; Dinanian S; Eliahou L; Samuel D; Adams D; Le Guludec D; Slama MS; Rouzet F
    JACC Cardiovasc Imaging; 2016 Dec; 9(12):1432-1441. PubMed ID: 27838303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced myocardial 123-iodine metaiodobenzylguanidine uptake: a prognostic marker in familial amyloid polyneuropathy.
    Coutinho MC; Cortez-Dias N; Cantinho G; Conceição I; Oliveira A; Bordalo e Sá A; Gonçalves S; Almeida AG; de Carvalho M; Diogo AN
    Circ Cardiovasc Imaging; 2013 Sep; 6(5):627-36. PubMed ID: 23833285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selected Mildly Obese Donors Can Be Used Safely in Simultaneous Pancreas and Kidney Transplantation.
    Alhamad T; Malone AF; Lentine KL; Brennan DC; Wellen J; Chang SH; Chakkera HA
    Transplantation; 2017 Jun; 101(6):1159-1166. PubMed ID: 27428713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term follow-up of survival of liver transplant recipients with familial amyloid polyneuropathy (Portuguese type).
    Suhr OB; Ericzon BG; Friman S
    Liver Transpl; 2002 Sep; 8(9):787-94. PubMed ID: 12200779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Patisiran, an RNA Interference Therapeutic, on Cardiac Parameters in Patients With Hereditary Transthyretin-Mediated Amyloidosis.
    Solomon SD; Adams D; Kristen A; Grogan M; González-Duarte A; Maurer MS; Merlini G; Damy T; Slama MS; Brannagan TH; Dispenzieri A; Berk JL; Shah AM; Garg P; Vaishnaw A; Karsten V; Chen J; Gollob J; Vest J; Suhr O
    Circulation; 2019 Jan; 139(4):431-443. PubMed ID: 30586695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effect of Augmenting OPTN Data With External Death Data on Calculating Patient Survival Rates After Organ Transplantation.
    Wilk AR; Edwards LB; Edwards EB
    Transplantation; 2017 Apr; 101(4):836-843. PubMed ID: 27547866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. United network for organ sharing outcomes after heart transplantation for al compared to ATTR cardiac amyloidosis.
    Griffin JM; Chiu L; Axsom KM; Bijou R; Clerkin KJ; Colombo P; Cuomo MO; De Los Santos J; Fried JA; Goldsmith J; Habal M; Haythe J; Helmke S; Horn EM; Latif F; Hi Lee S; Lin EF; Naka Y; Raikhelkar J; Restaino S; Sayer GT; Takayama H; Takeda K; Teruya S; Topkara V; Tsai EJ; Uriel N; Yuzefpolskaya M; Farr MA; Maurer MS
    Clin Transplant; 2020 Oct; 34(10):e14028. PubMed ID: 32623785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapidly Progressive Transthyretin-Mediated Amyloidosis in a Domino Liver Transplant Recipient of a Ser23Asn Donor.
    Dixit N; Castano A; Farr MJ; Traub R; Lentzsch S; Brown RS; Maurer MS; Brannagan TH
    J Clin Neuromuscul Dis; 2016 Mar; 17(3):142-5. PubMed ID: 26905915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of domino liver transplantation compared to deceased donor liver transplantation: a propensity-matching approach.
    Geyer ED; Burrier C; Tumin D; Hayes D; Black SM; Washburn WK; Tobias JD
    Transpl Int; 2018 Nov; 31(11):1200-1206. PubMed ID: 29907976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretransplant model to predict posttransplant survival in liver transplant patients.
    Ghobrial RM; Gornbein J; Steadman R; Danino N; Markmann JF; Holt C; Anselmo D; Amersi F; Chen P; Farmer DG; Han S; Derazo F; Saab S; Goldstein LI; McDiarmid SV; Busuttil RW
    Ann Surg; 2002 Sep; 236(3):315-22; discussion 322-3. PubMed ID: 12192318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cause of death analysis and temporal trends in survival after liver transplantation for transthyretin familial amyloid polyneuropathy.
    Algalarrondo V; Antonini T; Théaudin M; Chemla D; Benmalek A; Castaing D; Cauquil C; Rouzet F; Mika D; Duong E; Dinanian S; Eliahou L; Le Guludec D; Samuel D; Adams D; Slama MS
    Amyloid; 2018 Dec; 25(4):253-260. PubMed ID: 30632809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative risk factors predict survival following cardiac retransplantation: analysis of the United Network for Organ Sharing database.
    Belli E; Leoni Moreno JC; Hosenpud J; Rawal B; Landolfo K
    J Thorac Cardiovasc Surg; 2014 Jun; 147(6):1972-7, 1977.e1. PubMed ID: 24636155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donor Age Still Matters in Liver Transplant: Results From the United Network for Organ Sharing-Scientific Registry of Transplant Recipients Database.
    Montenovo MI; Hansen RN; Dick AAS; Reyes J
    Exp Clin Transplant; 2017 Oct; 15(5):536-541. PubMed ID: 27759559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of long-term survival after liver transplantation for familial transthyretin amyloidosis.
    Algalarrondo V; Antonini T; Théaudin M; Ducot B; Lozeron P; Chemla D; Benmalek A; Lacroix C; Azoulay D; Castaing D; Cauquil C; Rouzet F; Dinanian S; Eliahou L; Le Guludec D; Samuel D; Slama MS; Adams D
    J Am Coll Cardiol; 2015 Nov; 66(19):2154-2156. PubMed ID: 26541929
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of acquired transthyretin amyloidosis in domino liver transplantation.
    Tsamis KI; Mytilinaios D; Heneghan M; Gillmore JD; Gilbertson JA; Giannopoulos S; Sarmas I; Konitsiotis S
    Clin Transplant; 2023 Jan; 37(1):e14822. PubMed ID: 36128766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.